BioTheryX
PrivateLast Round
Corporate Funding
Apr 5, 2023
Total Funding Raised
$131.5M
Company Overview
BioTheryX is a biopharmaceutical company that develops innovative treatments for life-threatening diseases through targeted protein degradation and molecular glues.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioTheryX Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
BioTheryX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Apr 5, 2023 | ||||
| Series E | May 20, 2021 | ||||
| Series D | Jul 28, 2020 | ||||
| Series A | Nov 30, 2010 |
Key People
Founding team and executive leadership
BioTheryX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series E |
| Janus Henderson Group | Series E |
| Wedbush Healthcare Partners | Series E |
| Farallon Capital Management | Series E |
| Deep Track Capital | Series E |
| Avidity Partners | Series E |
| Irving Investors | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2021
$92M round led by Farallon Capital Management.
- Nov 30, 2010
$4.5M round led by Blood Cancer United
BioTheryX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioTheryX's valuation, stock price, and market status.